DeTOXing exhausted T cells may bolster CAR T immunotherapy against solid tumours

De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumours

A decade ago researchers announced development of a cancer immunotherapy called CAR (for chimeric antigen receptor)-T, in which a patient is re-infused with their own genetically modified T cells equipped to mount a potent anti-tumour attack. Since then...

More From BioPortfolio on "De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumours"